Gain insights into the operational challenges facing clinical research sites today, learn what sponsors and CROs can do to ...
Strong relational governance between technology vendors and sponsor–CRO teams is becoming a critical foundation for eCOA ...
In today’s ACT Brief, we look at how AI and in-silico methods are reshaping drug repurposing, why staggered ICH GCP rollouts ...
ACT: As new ICH GCP guidelines roll out, how are sponsors balancing the drive for innovation—especially in areas like CAR-T ...
In today’s ACT Brief, we look at what’s fueling rapid growth in CNS and autoimmune research, why former FDA leaders are ...
The FDA has launched a secure, GovCloud-based agentic AI system to support regulatory workflows across review divisions, ...
Chen: Yes, obesity is experiencing accelerated growth over the last couple of years. According to our sister product Evaluate ...
In today’s ACT Brief, we look at new insights on strategy-driven clinical development, fresh survey data revealing persistent ...
For industry-sponsored trials in autoimmune inflammation therapeutic areas, the dominating indications include atopic ...
Examine the rise of personalized and biomarker-driven therapies, the logistical challenges of rare patient populations, and ...
In today’s ACT Brief, we examine how the FDA’s CNPV Program is reshaping operational planning and accelerated submission ...
With the right technology and support, CRAs can continue their evolution into powerful agents of trial success that bridge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results